Supreme Court Won't Hear Patent Dispute Over Cox-2 Inhibitors

Law360, New York (November 30, 2004, 12:00 AM EST) -- The U.S. Supreme Court has refused to hear the University of Rochester’s appeal in its patent dispute with makers of cox-2 inhibitor pain killers, ending a legal battle that has cost the school $10 million.

Without explanation, the high court denied the school's request for a review of lower court rulings that dismissed its patent infringement claims against Pfizer Inc. and Merck & Co. over the class of anti-inflammatory drugs.

"We are, of course, very disappointed in the Supreme Court's decision," University of Rochester President Thomas...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.